Patient Identification

Is ZYNTEGLO right for your patient?

ZYNTEGLO is a one-time gene therapy that expands options for patients with TDT ≥12 years of age who do not have a β00 genotype and who do not have an HLA-matched related donor1 

CONSIDER TREATMENT FOR PATIENTS WHO MEET THESE CRITERIA:

  • Diagnosed with TDT1
  • Who do not have a β00 genotype1
  • Patients ≥12 years of age1
  • Appropriate for HSCT1
  • No HLA–matched related HSC donor available1
CONTRAINDICATIONS
  • Hypersensitivity to the active substance or to any of the excipients1
  • Pregnancy and breastfeeding1
  • Previous treatment with HSC gene therapy1
  • Contraindications to the mobilisation agents and the myeloablative conditioning agent must be considered1
Please consult the full EU Summary of Product Characteristics (EU SmPC) before prescribing.